PROMAKHOS THERAPEUTICS
Promakhos Therapeutics is building a platform of bacterial molecules to awaken the human body’s innate ability to control inflammation and heal.
PROMAKHOS THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2021-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.promakhos.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
125 K USD
Technology used in webpage:
Amazon YouTube Twitter Tweet Button Google Identity Platform Facebook Like Button Google Plus One Button
Similar Organizations
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Employees Featured
Founder
Investors List
Asymmetry Ventures
Asymmetry Ventures investment in Seed Round - Promakhos Therapeutics
Pioneer Fund
Pioneer Fund investment in Seed Round - Promakhos Therapeutics
Founders, Inc.
Founders, Inc. investment in Seed Round - Promakhos Therapeutics
Ethan Oren Perlstein
Ethan Oren Perlstein investment in Seed Round - Promakhos Therapeutics
PROTOCOL — by GETTYLAB
PROTOCOL — by GETTYLAB investment in Pre Seed Round - Promakhos Therapeutics
Y Combinator
Y Combinator investment in Pre Seed Round - Promakhos Therapeutics
Allston Venture Fund
Allston Venture Fund investment in Pre Seed Round - Promakhos Therapeutics
Official Site Inspections
http://www.promakhos.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Promakhos Therapeutics"
Promakhos Therapeutics - LinkedIn
Propel a Cure is an all-volunteer nonprofit organization that focuses on the needs of Crohn's patients, their families, friends, and caregivers. ... Promakhos Therapeutics | 348 followers on ...See details»
Crohn's Disease and IBD Research Projects - Propelacure
Propel A Cure is an all-volunteer nonprofit organization that raises funds for innovative research focused specifically on identifying the underlying cause or causes of Crohn’s disease, the first step in the development of a cure. ...See details»
Promakhos Therapeutics - Crunchbase Company …
Promakhos Therapeutics closed its last funding round on Sep 2, 2021 from a Seed round. Who are Promakhos Therapeutics 's competitors? Alternatives …See details»
Promakhos Therapeutics
Promakhos Therapeutics. ... Colombel was previously the President of the European Crohn’s and Colitis Organization (ECCO) (2008–2010) and Chair of the International Organization for the …See details»
Promakhos Therapeutics
Promakhos Therapeutics. Though inflammation is normally a healthy part of the body’s response to injury or infection, some people experience a dysfunctional immune response. The resulting …See details»
Promakhos Therapeutics - Y Combinator
I founded Promakhos because I think we have given to “autoimmune” diseases a grossly misleading name and we treat them in a primitive way. Promakhos means the first to enter a …See details»
Promakhos Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Promakhos Therapeutics Inc. of Somerville, MA. Get the latest business insights from Dun & Bradstreet.See details»
Promakhos Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 2, 2021: Seed Round - …See details»
Meet Promakhos Therapeutics | 2023 Harvard President's
May 24, 2023 Promakhos Therapeutics, a finalist in the Alumni & Affiliates Health & Life Sciences Track, develops cures for autoimmune diseases that affect millions of pa...See details»
Promakhos Therapeutics - PitchBook
Promakhos Therapeutics General Information Description. Developer of immunotherapies designed for the treatment of inflammatory diseases. The company has developed modulators of innate immune receptors for the …See details»
Promakhos Therapeutics - Contacts, Employees, Board Members, …
Organization. Promakhos Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. …See details»
Promakhos Therapeutics - Harvard Innovation Labs
Promakhos Therapeutics is developing cures for autoimmune diseases. Millions of people suffer from autoimmunity, yet there is currently no cure. Existing treatments focus on blocking the …See details»
Promakhos Therapeutics - Products, Competitors, Financials, …
Promakhos is a biotech firm that investigates approaches to treat chronic inflammatory diseases such as Crohn's disease, by regulating the function of the innate immune system. Use the CB …See details»
Meet Promakhos Therapeutics | 2024 Harvard President's
May 16, 2024 Promakhos Therapeutics is developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders.Learn more about Promakhos: https://...See details»
Promakhos Therapeutics - BIO International Convention | BIO
Jun 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... At …See details»
Promakhos Therapeutics - VentureRadar
Promakhos Therapeutics is developing new drugs for inflammatory disorders. Current therapies are immunosuppressive, do not work very well, often require injection and can cause …See details»
Promakhos Therapeutics | VentureRadar
Similar Companies: Origami Therapeutics USA Privately Held Origami Therapeutics is a preclinical-stage biopharmaceutical company that focuses on developing novel protein …See details»
Promakhos Therapeutics with Greek co-founder creates solutions …
Jan 24, 2022 A company with a Greek co-founder, Katerina Chatzi, develops molecules inspired by the bacteria that inhabit the body, aiming to awaken its innate ability to cure …See details»
Promakhos Therapeutics
Promakhos Therapeutics has closed its first round of financing after participating in the summer 2021 batch of Y Combinator, a Silicon Valley accelerator. The newly raised funds will be used …See details»